311 related articles for article (PubMed ID: 31138790)
1. Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
Wu G; Wang Q; Xu Y; Li J; Zhang H; Qi G; Xia Q
Cell Death Dis; 2019 May; 10(6):416. PubMed ID: 31138790
[TBL] [Abstract][Full Text] [Related]
2. LXR agonist treatment of blastic plasmacytoid dendritic cell neoplasm restores cholesterol efflux and triggers apoptosis.
Ceroi A; Masson D; Roggy A; Roumier C; Chagué C; Gauthier T; Philippe L; Lamarthée B; Angelot-Delettre F; Bonnefoy F; Perruche S; Biichle S; Preudhomme C; Macintyre E; Lagrost L; Garnache-Ottou F; Saas P
Blood; 2016 Dec; 128(23):2694-2707. PubMed ID: 27702801
[TBL] [Abstract][Full Text] [Related]
3. Celastrol induces lipophagy via the LXRα/ABCA1 pathway in clear cell renal cell carcinoma.
Zhang CJ; Zhu N; Long J; Wu HT; Wang YX; Liu BY; Liao DF; Qin L
Acta Pharmacol Sin; 2021 Sep; 42(9):1472-1485. PubMed ID: 33303989
[TBL] [Abstract][Full Text] [Related]
4. The liver X receptors and sterol regulatory element binding proteins alter progesterone secretion and are regulated by human chorionic gonadotropin in human luteinized granulosa cells.
Xu Y; Hernández-Ledezma JJ; Hutchison SM; Bogan RL
Mol Cell Endocrinol; 2018 Sep; 473():124-135. PubMed ID: 29366778
[TBL] [Abstract][Full Text] [Related]
5. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation.
Chu K; Miyazaki M; Man WC; Ntambi JM
Mol Cell Biol; 2006 Sep; 26(18):6786-98. PubMed ID: 16943421
[TBL] [Abstract][Full Text] [Related]
6. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
7. TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.
Hsieh J; Koseki M; Molusky MM; Yakushiji E; Ichi I; Westerterp M; Iqbal J; Chan RB; Abramowicz S; Tascau L; Takiguchi S; Yamashita S; Welch CL; Di Paolo G; Hussain MM; Lefkowitch JH; Rader DJ; Tall AR
Nature; 2016 Jul; 535(7611):303-7. PubMed ID: 27383786
[TBL] [Abstract][Full Text] [Related]
8. 25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway.
Ma Y; Xu L; Rodriguez-Agudo D; Li X; Heuman DM; Hylemon PB; Pandak WM; Ren S
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1369-79. PubMed ID: 18854425
[TBL] [Abstract][Full Text] [Related]
9. Liver X Receptor Agonist TO901317 Prevents Diacylglycerols Accumulation in the Heart of Streptozotocin-Diabetic Rats.
Harasiuk D; Baranowski M; Zabielski P; Chabowski A; Górski J
Cell Physiol Biochem; 2016; 39(1):350-9. PubMed ID: 27352290
[TBL] [Abstract][Full Text] [Related]
10. Polyphenol-rich black chokeberry (Aronia melanocarpa) extract regulates the expression of genes critical for intestinal cholesterol flux in Caco-2 cells.
Kim B; Park Y; Wegner CJ; Bolling BW; Lee J
J Nutr Biochem; 2013 Sep; 24(9):1564-70. PubMed ID: 23517916
[TBL] [Abstract][Full Text] [Related]
11. Expression of SREBP-1c Requires SREBP-2-mediated Generation of a Sterol Ligand for LXR in Livers of Mice.
Rong S; Cortés VA; Rashid S; Anderson NN; McDonald JG; Liang G; Moon YA; Hammer RE; Horton JD
Elife; 2017 Feb; 6():. PubMed ID: 28244871
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes.
Fan J; Zareyan S; Zhao W; Shimizu Y; Pfeifer TA; Tak JH; Isman MB; Van den Hoven B; Duggan ME; Wood MW; Wellington CL; Kulic I
PLoS One; 2016; 11(9):e0162384. PubMed ID: 27598782
[TBL] [Abstract][Full Text] [Related]
13. 4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters.
Elia J; Carbonnelle D; Logé C; Ory L; Huvelin JM; Tannoury M; Diab-Assaf M; Petit K; Nazih H
Lipids Health Dis; 2019 Sep; 18(1):168. PubMed ID: 31477154
[TBL] [Abstract][Full Text] [Related]
14. Update on Mechanisms of Renal Tubule Injury Caused by Advanced Glycation End Products.
Sun H; Yuan Y; Sun Z
Biomed Res Int; 2016; 2016():5475120. PubMed ID: 27034941
[TBL] [Abstract][Full Text] [Related]
15. Chronic kidney disease alters lipid trafficking and inflammatory responses in macrophages: effects of liver X receptor agonism.
Kaseda R; Tsuchida Y; Yang HC; Yancey PG; Zhong J; Tao H; Bian A; Fogo AB; Linton MRF; Fazio S; Ikizler TA; Kon V
BMC Nephrol; 2018 Jan; 19(1):17. PubMed ID: 29374468
[TBL] [Abstract][Full Text] [Related]
16. VD
Munir MT; Ponce C; Santos JM; Sufian HB; Al-Harrasi A; Gollahon LS; Hussain F; Rahman SM
Mol Biol Rep; 2020 Oct; 47(10):7771-7782. PubMed ID: 32990902
[TBL] [Abstract][Full Text] [Related]
17. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation.
Wang X; Cheng Y; Zhu Y; Li H; Ge W; Wu X; Zhao K; Yuan J; Li Z; Jiang S; Han Z; Jiang Q; Wu Q; Liu T; Zhang C; Yu M; Hu Y
Int J Cancer; 2017 Oct; 141(7):1422-1433. PubMed ID: 28656647
[TBL] [Abstract][Full Text] [Related]
19. Impairment of trophoblast survival and differentiation by LXR ligands is prevented by cholesterol but not ABCA1 silencing.
Harmon CM; McGonigal S; Larkin JC
Placenta; 2018 Sep; 69():50-56. PubMed ID: 30213484
[TBL] [Abstract][Full Text] [Related]
20. Induction of SREBP-1c mRNA by differentiation and LXR ligand in human keratinocytes.
Yokoyama A; Makishima M; Choi M; Cho Y; Nishida S; Hashimoto Y; Terui T
J Invest Dermatol; 2009 Jun; 129(6):1395-401. PubMed ID: 19242521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
